Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.9K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prenatal e-cigarette exposure induces region- and cell type-specific metabolic and developmental reprogramming.

bioRxiv : the preprint server for biology·2026
Same author

Astrocytic D1 Dopamine-Signaling Regulates Synaptic Remodeling and Cocaine Seeking.

bioRxiv : the preprint server for biology·2026
Same author

Prenatal THC exposure disrupts mitochondrial respiratory gene programs and medium spiny neuron maturation trajectories in the nucleus accumbens.

bioRxiv : the preprint server for biology·2026
Same author

Retraction notice to 'HIF-1α inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model' [Neurobiology of Disease 31 (2008) 433-441].

Neurobiology of disease·2026
Same author

Silk Fibroin-Modified Metal Organic Framework Acid-Controlled Release Nanocarrier for Polyetheretherketone to Combat Implant-Associated Infections and Promote Angiogenesis.

Advanced healthcare materials·2026
Same author

Enhanced Bone Formation in Segmental Defect Healing Using 3D Printed Scaffolds Containing Bone Marrow Stromal Cells and Small Molecules Targeting Chondrogenesis and Osteogenesis.

Biomedicines·2026

Related Experiment Video

Updated: Apr 7, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.1K

PDGFB-based stem cell gene therapy increases bone strength in the mouse.

Wanqiu Chen1, David J Baylink1, Justin Brier-Jones1

  • 1Department of Medicine, Loma Linda University, Loma Linda, CA 92354;

Proceedings of the National Academy of Sciences of the United States of America
|July 8, 2015
PubMed
Summary

This study demonstrates that overexpressing PDGFB in stem cells safely enhances bone formation and strength, offering a promising therapy for osteoporosis and fracture risk, especially after HSC transplantation.

Keywords:
PDGFBbone formationgene therapyhematopoietic stem cells

More Related Videos

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
05:10

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Published on: February 7, 2025

803
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

1.0K

Related Experiment Videos

Last Updated: Apr 7, 2026

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis
03:40

Author Spotlight: Exploring the Lifespan Dynamics of Healthy Human Hematopoiesis

Published on: December 8, 2023

2.1K
Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model
05:10

Improved Methodology for Studying Postnatal Osteogenesis via Intramembranous Ossification in a Murine Bone Marrow Injury Model

Published on: February 7, 2025

803
In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells
05:32

In Vivo Osteo-organoid Approach for Harvesting Therapeutic Hematopoietic Stem/Progenitor Cells

Published on: February 16, 2024

1.0K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Skeletal Biology

Background:

  • Current osteoporosis treatments do not fully eliminate fracture risk or rejuvenate bone.
  • Previous attempts using FGF2-engineered stem cells showed increased bone formation but caused adverse effects like hyperparathyroidism and osteomalacia.

Purpose of the Study:

  • To investigate PDGFB as a safer alternative gene therapy for osteoporosis.
  • To evaluate the efficacy of PDGFB-engineered stem cells in improving bone mass, structure, and strength.

Main Methods:

  • Hematopoietic stem/progenitor cells (HSCs) or Sca1(+) cells were genetically modified to overexpress PDGFB using a phosphoglycerate kinase (PGK) promoter.
  • The effects of transplanted PGK-PDGFB-transduced Sca1(+) cells on bone formation, structure, and strength were assessed.
  • Mesenchymal stem cell (MSC) proliferation and differentiation in response to PDGF-BB were analyzed.

Main Results:

  • Modest PDGFB overexpression via the PGK promoter prevented osteomalacia and secondary hyperparathyroidism.
  • Significant increases in trabecular bone formation and connectivity were observed.
  • Cortical porosity decreased, leading to a 45% increase in bone strength.
  • Transplanted cells promoted MSC proliferation and osteogenic differentiation.

Conclusions:

  • PGK-PDGFB-transduced Sca1(+) cell transplantation is a safe and effective therapy for enhancing bone regeneration and strength.
  • This approach holds potential for treating osteoporosis and preventing fractures, particularly in patients undergoing HSC transplantation.
  • Further research may enable broader clinical applications without the need for preconditioning.